Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Y011267 | IM / RL |
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5H773 | IM / RL |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | X021477 | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | HR3649 | IM / LL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y005921 | SC / RL |
Patient presented to emergency room in status epilepticus at 23:25 on 5/5/25 after receiving the above vaccines at PCP earlier in the day. Per documentation, Mother noted tactile fever around 22:00. Around 22:30 saw shaking in his arm and twitching in his face. This lasted around 5 minutes before they called EMS. He was given a dose of IN versed and transported to ED. In the ED, there was concern he was in subclinical status so received 2 doses of Ativan and a Keppra load. He subsequently got intubated for concern for acute respiratory failure and and transferred to the PICU. History only of global developmental delay. Immigrated about 2 months ago.
Blood work unrevealing, culture pending; UA unremarkable, culture pending, respiratory viral panel negative, CT showed decreased volume, all done on 5/5. MRI to be done today, 5/6.